The IAP family of proteins are key regulators of apoptosis, involved in suppressing cell death in response to viral infections and in various diseases. These proteins contain a conserved baculoviral IAP repeat (BIR) domain, which is essential for their anti-apoptotic function. Some IAPs also contain additional domains such as RING, CARD, and UBC, which may contribute to their function. The IAP family includes proteins such as XIAP, c-IAP1, c-IAP2, Survivin, and BRUCE, which are expressed in various tissues and have roles in cell survival, proliferation, and differentiation. IAPs inhibit apoptosis by directly binding and inhibiting caspases, which are key enzymes in the apoptotic pathway. This inhibition can occur at different stages of the apoptotic cascade, including the activation of caspase-8 and caspase-9. IAPs also interact with other signaling pathways, such as NF-κB and JNK, which can influence cell survival and death. In cancer, IAPs are involved in promoting cell survival and resistance to apoptosis, making them potential therapeutic targets. Survivin, a member of the IAP family, is highly expressed in many cancers and is associated with poor prognosis. IAPs can also be involved in neuronal cell death and in the regulation of cell cycle progression. The study of IAPs has revealed their evolutionary conservation and their role in various biological processes, including immune response, development, and disease. Understanding the mechanisms by which IAPs regulate apoptosis and cell death is important for developing new therapeutic strategies for diseases involving dysregulated apoptosis.The IAP family of proteins are key regulators of apoptosis, involved in suppressing cell death in response to viral infections and in various diseases. These proteins contain a conserved baculoviral IAP repeat (BIR) domain, which is essential for their anti-apoptotic function. Some IAPs also contain additional domains such as RING, CARD, and UBC, which may contribute to their function. The IAP family includes proteins such as XIAP, c-IAP1, c-IAP2, Survivin, and BRUCE, which are expressed in various tissues and have roles in cell survival, proliferation, and differentiation. IAPs inhibit apoptosis by directly binding and inhibiting caspases, which are key enzymes in the apoptotic pathway. This inhibition can occur at different stages of the apoptotic cascade, including the activation of caspase-8 and caspase-9. IAPs also interact with other signaling pathways, such as NF-κB and JNK, which can influence cell survival and death. In cancer, IAPs are involved in promoting cell survival and resistance to apoptosis, making them potential therapeutic targets. Survivin, a member of the IAP family, is highly expressed in many cancers and is associated with poor prognosis. IAPs can also be involved in neuronal cell death and in the regulation of cell cycle progression. The study of IAPs has revealed their evolutionary conservation and their role in various biological processes, including immune response, development, and disease. Understanding the mechanisms by which IAPs regulate apoptosis and cell death is important for developing new therapeutic strategies for diseases involving dysregulated apoptosis.